Vagina antibacterial care composition, vagina antibacterial care solution and preparation method of vagina antibacterial care composition and vagina antibacterial care solution

Through the synergistic efficiency of multiple targets in the vaginal antibacterial care composition, the health problems caused by vaginal microecology imbalance are solved, viral infection and harmful bacteria are significantly inhibited, the immune defense function of the vagina is improved, and the maintenance of vaginal health is achieved.

CN118924874APending Publication Date: 2024-11-12AMERICANA (LIAONING) PHARM CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410971067.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-19
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

The prior art is difficult to effectively maintain the health of women's vagina, especially when vaginal microbial imbalance is unbalanced, which cannot effectively inhibit viral infection, maintain moisturization and immune defense functions.

Method used

Using a vaginal antibacterial care composition, including viral inhibitors, microecological balancers, plant hormones, bactericidal anti-itching agents and antibacterial peptides, fermentation through purpura extract, yellow bark tree extract, astragalus extract, and lactic acid bacteria Components such as products, α-glucan oligosaccharides, Bacillus fermentation products, etc. form multi-target synergistic efficiency, significantly inhibit viral infection and regulate vaginal microecological balance.

Benefits of technology

It significantly enhances the vagina's clean and antibacterial effect, improves the immune defense function, maintains the vagina's microecological balance, improves vaginal health, and has a significant inhibitory effect on harmful bacteria.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004953223880000071
    Figure BDA0004953223880000071
  • Figure BDA0004953223880000081
    Figure BDA0004953223880000081
  • Figure BDA0004953223880000082
    Figure BDA0004953223880000082
Patent Text Reader

Abstract

The invention belongs to the technical field of pharmaceutical preparations, and particularly relates to a vagina antibacterial care composition, a vagina antibacterial care solution and a preparation method of the vagina antibacterial care composition and the vagina antibacterial care solution. The vagina antibacterial nursing composition is prepared from the following components in parts by weight: 1 to 5 parts of virus inhibitor, 1 to 4 parts of micro-ecological balance agent, 2 to 6 parts of plant hormone, 1 to 4 parts of bactericidal antipruritic agent, 0.5 to 2 parts of triphosadenine and 1 to 3 parts of antibacterial peptide, the virus inhibitor is prepared from radix arnebiae seu lithospermi extract, clausena lansium extract and radix astragali seu hedysari extract; the micro-ecological balance agent is prepared from alpha-glucan oligosaccharide and a bacillus fermentation product. The components are matched with one another, multi-target-point synergistic interaction is achieved, the effects of cleaning, bacteriostasis, virus infection prevention, mildness, no stimulation and the like of the product are remarkably enhanced, the self-cleaning capacity and the immune defense function of the vagina can be effectively improved, and important significance is achieved for maintaining micro-ecological balance of the female vagina and maintaining vagina health.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of pharmaceutical preparations, and in particular relates to a vaginal antibacterial care composition, a vaginal antibacterial care solution and a preparation method thereof. Background Art

[0002] The female vagina is an important microecological area for women, and vaginal health problems caused by vaginal microecological imbalance are receiving more and more attention. Vaginal microecological imbalance is caused by a variety of factors, including (1) endogenous factors: changes in hormone levels during physiological processes such as menstruation, pregnancy, and menopause may affect the vaginal microecology; long-term or frequent use of antibiotics may disrupt the normal microecological balance in the body, including the microbial community inside the vagina; (2) daily life factors: an unbalanced diet with high sugar, high fat, and low fiber may cause intestinal microecological imbalance, thereby affecting the overall microecological balance, including the vagina; sleep quality, stress level, exercise frequency, etc. may also have an impact on the microecology; improper cleaning or excessive cleaning, and the use of lotions containing too much fragrance, etc. The imbalance of female vaginal microecology is the main cause of repeated attacks of gynecological vulvar inflammation. Improving the vaginal microenvironment, keeping the vagina moist, maintaining the balance of vaginal microecology, improving vaginal cleanliness, and enhancing vaginal mucosal immunity and preventing viral infections are of great significance for maintaining female vaginal health.

[0003] Therefore, it is necessary and urgent to research and develop a female private care product that has the effects of cleaning, inhibiting bacteria, preventing viral infection, maintaining moisture, being mild and non-irritating, and can also balance the pH value of the female private parts, improve the vaginal self-cleaning ability and immune defense function. Summary of the invention

[0004] The purpose of the present invention is to overcome the shortcomings and deficiencies of the prior art and provide a vaginal antibacterial care composition, a vaginal antibacterial care solution and a preparation method thereof, so as to achieve good cleaning and antibacterial effects and effectively enhance the immune defense function, thereby maintaining female vaginal health.

[0005] To achieve the above objectives, the technical solutions adopted by the present invention include:

[0006] In a first aspect, the present invention provides a vaginal antibacterial care composition, which comprises the following components in parts by weight: 1-5 parts of viral inhibitors, 1-4 parts of microecological balancers, 2-6 parts of plant hormones, 1-4 parts of bactericidal and antipruritic agents, 0.5-2 parts of adenosine triphosphate and 1-3 parts of antibacterial peptides; the viral inhibitors comprise lithospermum officinale extract, phellodendron chinense extract, astragalus extract, propylene glycol, lactic acid bacteria fermentation products and water; the microecological balancers comprise α-glucan oligosaccharides, bacillus fermentation products, 1,2-hexanediol and water.

[0007] The present invention adopts lithospermum extract, phellodendron chinense extract, astragalus extract, propylene glycol, lactic acid bacteria fermentation product and water to prepare the virus inhibitor. When the virus inhibitor is applied to the vaginal antibacterial care composition of the present invention, the components cooperate with each other, and through multi-target synergistic enhancement, the virus including HPV can be significantly inhibited and eliminated, the virus is blocked from infection again, and the effects of clearing away heat and dampness, anti-oxidation and antipruritic are exerted.

[0008] The α-glucan oligosaccharide (IMO) in the microecological balance agent has the effects of promoting the proliferation and colonization of vaginal lactobacilli, inhibiting the growth of harmful bacteria and the generation of putrefactive substances; the Bacillus fermentation product (MOS) is a new type of prebiotic, which can significantly activate and proliferate lactic acid bacteria, adsorb and excrete intestinal pathogens, and regulate the microecological balance. In addition, it has immunogenicity and can effectively stimulate immune response, thereby regulating the local immune function of the vagina; when the two are compounded as a microecological balance agent and applied to the vaginal antibacterial care composition of the present invention, the cleaning and antibacterial effect of the composition can be significantly improved, the vaginal immune defense function can be enhanced, and the vaginal microecological balance can be effectively maintained.

[0009] Adenosine triphosphate (ATP), as a high-energy phosphate compound, can effectively ensure the energy supply for various life activities of cells, promote the repair and regeneration of various cells in the body, enhance cell metabolic activity, and thus assist mucosal regeneration; the main active substance in antimicrobial peptides - lactic acid bacteria fermentation products have excellent bactericidal properties, fast effects, and can enhance the body's immune function, and exert anti-inflammatory, antipruritic, moisturizing and repair effects.

[0010] The invention prepares a vaginal antibacterial care composition by scientifically combining the prepared virus inhibitor and microecological balancer with other components, and compounding them within a limited weight range. The components cooperate with each other, influence each other, and give full play to their functions. At the same time, multiple targets synergize and enhance the efficacy, significantly enhancing the cleaning and antibacterial, anti-viral infection, mild and non-irritating effects of the finally prepared vaginal antibacterial care liquid product, and can effectively improve the vaginal self-cleaning ability and immune defense function, which is of great significance for maintaining the microecological balance of the female vagina and maintaining vaginal health.

[0011] Preferably, the vaginal antibacterial care composition comprises the following components in parts by weight: 1-1.5 parts of virus inhibitors, 1.5-2.5 parts of microecological balancers, 3.3-5 parts of plant hormones, 1.6-2.4 parts of bactericidal and antipruritic agents, 0.8-1.2 parts of adenosine triphosphate and 1.5-2.5 parts of antimicrobial peptides.

[0012] Preferably, the vaginal antibacterial care composition comprises the following components in parts by weight: 1 part of virus inhibitor, 2 parts of microecological balancing agent, 4 parts of plant hormones, 2 parts of bactericidal and antipruritic agents, 1 part of adenosine triphosphate and 2 parts of antimicrobial peptides.

[0013] Through experimental research, it was found that when the weight of each component in the vaginal antibacterial care composition is at the optimal value described in the present invention, the antibacterial care liquid product prepared by the composition has the best inhibitory effect on various harmful bacteria such as Streptococcus albus, Escherichia coli, and Staphylococcus aureus, and can significantly promote the proliferation of Lactobacillus crispatus, thereby effectively improving the self-cleaning ability of the vagina, and has a significant effect on the recovery of vaginal inflammation symptoms.

[0014] The inventors also explored the dosage of each raw material and found that if the dosage of the virus inhibitor, microecological balancer and antimicrobial peptide raw materials is too small or the total dosage of the three is too small, the synergistic effect is not obvious. If the dosage of the raw materials is too large or the total dosage of the three is too large, antagonism may occur, which will also lead to a decrease in the antibacterial effect. This shows that the above-mentioned raw materials have a more ideal synergistic effect when they are within the specified range of the present invention.

[0015] Preferably, the virus inhibitor comprises the following components in percentage by mass: 10-25% of Lithospermum officinale extract, 10-20% of Phellodendron chinense extract, 10-20% of Astragalus membranaceus extract, 10-20% of propylene glycol, 0.5-3% of lactic acid bacteria fermentation product and the balance of water;

[0016] The microecological balancing agent comprises the following components in percentage by mass: 20-30% of alpha-glucan oligosaccharide, 10-20% of bacillus fermentation product, 2-5% of 1,2-hexanediol and the balance of water.

[0017] Among them, the representative viral inhibitor is Ballesu, which includes the following components in percentage by mass: 20% Xinjiang Lithospermum officinale extract, 15% Phellodendron chinense extract, 15% Mongolian Astragalus extract, 15% propylene glycol, 1.5% lactic acid bacteria fermentation product and 33.5% water.

[0018] Among them, the representative microecological balancer is HORBIOME-V, which includes the following components in mass percentage: 20% α-glucan oligosaccharide, 10% Bacillus fermentation product, 2.2% 1,2-hexanediol and 67.8% water.

[0019] Experimental research has found that when the above-mentioned viral inhibitors and microecological balancer products are used, the vaginal antibacterial care composition prepared by compounding the two with the antibacterial peptides described in the present invention and other components can make the antibacterial care liquid product have excellent antibacterial effect, and better antipruritic, soothing, heat-clearing and dampness-drying effects.

[0020] Preferably, the antimicrobial peptide comprises the following components in percentage by mass: 15-25% of lactic acid bacteria fermentation product, 50-60% of propylene glycol and the balance of water.

[0021] Preferably, the plant hormone is a compound of kudzu root extract, chlorella extract, aloe vera leaf extract and soybean seed extract; the mass ratio of the total mass of the kudzu root extract, chlorella extract and aloe vera leaf extract to the soybean seed extract is (1-3): (1-3).

[0022] The present invention adopts four plant extracts, namely, kudzu root extract, chlorella extract, aloe vera leaf extract and wild soybean seed extract, as plant hormones and applied to the vaginal antibacterial care composition. The plant extracts can effectively promote the proliferation of skin fibroblasts, thereby improving skin elasticity, and can also exert a moisturizing effect. In addition, the wild soybean seed extract can also exert an estrogen-like effect on skin enzymes or collagen. Experimental exploration has found that when the four plant extracts are compounded as plant hormones and applied to the vaginal antibacterial care composition of the present invention, the heat-clearing and moisturizing effects of the antibacterial care solution product can be better improved, and the mucosal repair and regeneration can be effectively assisted.

[0023] Preferably, the bactericidal and antipruritic agent comprises oxymatrine and magnolioside, and the mass ratio of oxymatrine to magnolioside is oxymatrine: magnolioside=(0.5-2):(0.5-2).

[0024] The vaginal antibacterial care composition of the present invention also adds a bactericidal and antipruritic agent prepared by oxymatrine and magnolia glycosides. Oxymatrine, as a bidirectional immunomodulator, can stimulate lymphocyte proliferation at low concentrations and promote the ability of skin cells to resist adverse external environments, while at high concentrations it produces an immunosuppressive effect, that is, it can regulate the release of inflammatory mediators in cells to prevent cells from being in an over-excited state, and has antipruritic, anti-allergic and anti-inflammatory effects; magnolia glycosides, as a new type of alkaloid, has good cell soothing effect, improves skin sensitivity, and has good relief and repair effects on skin itching, pain, etc.; when the two are compounded into a bactericidal and antipruritic agent using the above-mentioned specific dosage ratio and used in the vaginal antibacterial care composition, the anti-inflammatory and soothing effects of the product can be significantly enhanced, providing users with a more comfortable and gentle effect experience.

[0025] In a second aspect, the present invention provides a vaginal antibacterial care solution, comprising the vaginal antibacterial care composition; the mass percentage of the vaginal antibacterial care composition in the vaginal antibacterial care solution is 6.5-24%.

[0026] Preferably, the vaginal antibacterial care solution further comprises the following components in percentage by weight: riboflavin 1-3%, poloxamer 0.5-4%, bactericide 0.02-0.07%, solubilizer 0.5-1%, cosolvent 5-15%, surfactant 0.2-0.8%, pH regulator 5-6% and the balance water.

[0027] Preferably, the bactericide includes benzalkonium chloride; the solubilizer includes at least one of Tween 20, cocoether-7, PPG-1-PEG-9 lauryl glycol ether and PEG-40 hydrogenated castor oil; the cosolvent includes at least one of glycerol and propylene glycol; the surfactant includes disodium cocoamphodiacetate; and the pH adjuster includes lactic acid.

[0028] In a third aspect, the present invention provides a method for preparing the vaginal antibacterial care solution, comprising the following steps:

[0029] (1) placing the cosolvent and poloxamer in an emulsifier, homogenizing and stirring for 3-7 minutes, the homogenizing speed is 37-40 rpm / min, the stirring speed is 20-30 rpm / min, then adding water, homogenizing 2-4 times, each time for 2-4 minutes, the homogenizing speed is 38-42 rpm / min, the stirring speed is 38-42 rpm / min, then heating to 90° C., adjusting the stirring speed to 22-28 rpm / min, and keeping warm for 35-45 minutes to obtain a mixture I;

[0030] (2) stirring and mixing the solubilizer and the fungicide to obtain a mixture II, cooling the mixture I to 60-65° C. and adding the mixture II, and then adding a surfactant to obtain a mixture III;

[0031] (3) cooling the mixture III to 48-52° C., adding adenosine triphosphate, and keeping the temperature for 4-6 minutes, then adding a bactericidal and antipruritic agent, and keeping the temperature for 4-6 minutes to obtain a mixture IV;

[0032] (4) Cooling the mixture IV to 43-47° C., adding a pH regulator, riboflavin, plant hormones, antimicrobial peptides, virus inhibitors and microecological balance agents in sequence, stirring for 3-7 minutes each time each raw material is added. After the addition is completed, stirring is continued for 15-30 minutes to obtain the vaginal antibacterial care solution.

[0033] The present invention adds poloxamer to the vaginal antibacterial care solution to adjust the viscosity of the product and thus improve the carrier efficiency. The inventors have found through experimental research that when glycerol is used as a co-solvent and the above-mentioned process method is used, the poloxamer can be fully dissolved and the active ingredients can be effectively coated, thereby significantly improving the absorption effect of the active ingredients in the vaginal antibacterial care solution product.

[0034] Preferably, the pH value of the vaginal antibacterial care solution is controlled to be 4.2-5.

[0035] More preferably, the pH value of the vaginal antibacterial care solution is controlled to be 4.6.

[0036] The inventors have found through experimental research that when the pH value of the prepared vaginal antibacterial care solution is controlled within the above preferred range, it can better balance the pH value of the female private parts, thereby inhibiting the proliferation of harmful bacteria and improving the self-cleaning ability of the vagina.

[0037] Compared with the prior art, the present invention has the following beneficial effects:

[0038] The present invention prepares a vaginal antibacterial care composition by scientifically combining a virus inhibitor and a microecological balancer containing specific components with other components, and compounding them within a limited weight range. The components cooperate with each other and influence each other to give full play to their functions, while synergizing multiple targets, significantly enhancing the cleaning and antibacterial, anti-viral infection, mild and non-irritating effects of the finally prepared vaginal antibacterial care liquid product, and can effectively improve the vaginal self-cleaning ability and immune defense function, which is of great significance for maintaining the microecological balance of the female vagina and maintaining vaginal health. BRIEF DESCRIPTION OF THE DRAWINGS

[0039] Figure 1 The following are comparison pictures of the vulva of the subjects before (Figure A) and after (Figure B) using the vaginal antibacterial care solution described in Example 5 for 20 days. DETAILED DESCRIPTION

[0040] To better illustrate the purpose, technical solutions and advantages of the present invention, the present invention will be further described below in conjunction with specific embodiments. It should be understood by those skilled in the art that the specific embodiments described herein are only used to explain the present invention and are not intended to limit the present invention.

[0041] In this application, when it comes to numerical ranges, unless otherwise specified, the above numerical ranges are deemed to be continuous and include the minimum and maximum values ​​of the range, as well as each value between such minimum and maximum values. Further, when a range refers to an integer, each integer between the minimum and maximum values ​​of the range is included. In addition, when multiple ranges are provided to describe features or characteristics, the ranges can be merged. In other words, unless otherwise specified, all ranges disclosed herein should be understood to include any and all subranges included therein.

[0042] Unless otherwise specified, all raw materials involved in the following examples and comparative examples are commercially available general materials, and the component raw materials used in each parallel experiment are of the same kind; unless otherwise specified, the preparation method of the preparation is prepared by directly mixing the components using a conventional method.

[0043] The viral inhibitor described in the embodiment of the present invention is Ballesu, which includes the following components in percentage by mass: 20% Xinjiang Lithospermum officinale extract, 15% Phellodendron chinense extract, 15% Mongolian Astragalus membranaceus extract, 15% propylene glycol, 1.5% lactic acid bacteria fermentation product and 33.5% water.

[0044] The microecological balancing agent is HORBIOME-V, which includes the following components in percentage by mass: 20% of α-glucan oligosaccharide, 10% of bacillus fermentation product, 2.2% of 1,2-hexanediol and 67.8% of water.

[0045] The plant hormones include plant hormones I and plant hormones II, wherein the plant hormones I include kudzu root extract, chlorella extract, and aloe vera leaf extract, and the mass ratio of the kudzu root extract, the chlorella extract, and the aloe vera leaf extract is 3:1:1; the plant hormones II include soybean seed extract; the mass ratio of the plant hormones I and the plant hormones II is (1-3):(1-3), more preferably (1.8-2.5):(1.5-2.5);

[0046] The usage ratio of coconut ether-7, PPG-1-PEG-9 lauryl glycol ether and PEG-40 hydrogenated castor oil in the solubilizer is (3-5): (3-5): (1-2).

[0047] Examples 1-7

[0048] Table 1: Formula of vaginal antibacterial care solution described in Examples 1-7 (mass percentage %)

[0049]

[0050]

[0051]

[0052] Comparative Examples 1-16

[0053] Table 2: Formula of the vaginal antibacterial care solution described in Comparative Examples 1-8 (mass percentage %)

[0054]

[0055]

[0056] Table 3: Formula of the vaginal antibacterial care solution described in Comparative Examples 9-16 (mass percentage %)

[0057]

[0058]

[0059] Comparative Example 17

[0060] This comparative example provides a vaginal antibacterial care solution, which is different from Example 5 in that the lithospermum officinale extract and the phellodendron chinense extract in the virus inhibitor are replaced with water, and the components and contents thereof remain unchanged.

[0061] Comparative Example 18

[0062] This comparative example provides a vaginal antibacterial care solution, which is different from Example 5 in that: the Phellodendron chinense extract and Astragalus membranaceus extract in the virus inhibitor are replaced with water, and the components and contents thereof remain unchanged.

[0063] The preparation method of the vaginal antibacterial care solution described in Examples 1-7 and Comparative Examples 1-18 comprises the following steps:

[0064] (1) placing the cosolvent and poloxamer in an emulsifier, homogenizing and stirring for 3-7 minutes, the homogenizing speed is 37-40 rpm / min, the stirring speed is 20-30 rpm / min, then adding water, homogenizing 2-4 times, each time for 2-4 minutes, the homogenizing speed is 38-42 rpm / min, the stirring speed is 38-42 rpm / min, then heating to 90° C., adjusting the stirring speed to 22-28 rpm / min, and keeping warm for 35-45 minutes to obtain a mixture I;

[0065] (2) stirring and mixing the solubilizer and the fungicide to obtain a mixture II, cooling the mixture I to 60-65° C. and adding the mixture II, and then adding a surfactant to obtain a mixture III;

[0066] (3) cooling the mixture III to 48-52° C., adding adenosine triphosphate, and keeping the temperature for 4-6 minutes, then adding a bactericidal and antipruritic agent, and keeping the temperature for 4-6 minutes to obtain a mixture IV;

[0067] (4) cooling the mixture IV to 43-47° C., adding a pH regulator, riboflavin, plant hormones, antimicrobial peptides, virus inhibitors and microecological balance agents in sequence, stirring for 3-7 minutes each time a raw material is added, and stirring is continued for 15-30 minutes after the addition is completed to obtain the vaginal antibacterial care solution;

[0068] The pH value of the vaginal antibacterial care solution is controlled to be 4.2-5.

[0069] Effect Example 1

[0070] 1. Effect Example The vaginal antibacterial care solutions prepared in Examples 1-7 and Comparative Examples 1-18 were used as samples, and antibacterial tests on Staphylococcus aureus, Escherichia coli and Candida albicans were performed on them respectively to explore the antibacterial effect of the care solution products on harmful bacteria. The specific method is as follows.

[0071] 1. Test strains

[0072] (1) Staphylococcus aureus ATCC 6538, source: ATCC, 4th generation;

[0073] (2) Escherichia coli 8099, source: Guangdong Microbiological Culture Collection Center, 4th generation;

[0074] (3) Candida albicans ATCC 10231, source: ATCC, 4th generation.

[0075] 2. Detection method

[0076] (1) Testing basis: Appendix C of GB 15979-2002 Hygiene Standard for Disposable Hygiene Products;

[0077] (2) Test conditions: test environment temperature 20.2-23.8°C, relative humidity 50-53% HR, exposure time 20 min;

[0078] (3) Evaluation criteria: If the antibacterial rate is >50%-90%, the product has a strong antibacterial effect; if the antibacterial rate is >90%, the product has a strong antibacterial effect.

[0079] The antibacterial results are shown in Table 4.

[0080] Table 4

[0081]

[0082] From the results in Table 4, it can be seen that the vaginal antibacterial care solution prepared in Examples 1-7 of the present invention can achieve an inhibition rate of more than 95% against Staphylococcus aureus, Escherichia coli and Candida albicans, has an excellent bactericidal effect, and can effectively keep the private parts clean and healthy.

[0083] 2. This effect example uses the vaginal antibacterial care solution prepared in Examples 1-7 and Comparative Examples 1-18 as samples to conduct a proliferation test of Lactobacillus crispatus. The specific method is as follows.

[0084] About 1000-10000 Lactobacillus crispatus 1mL was added to 9mL sample to make the concentration of the tested bacteria about 100-1000 bacteria, and then 1mL was added to MRS broth and cultured anaerobically at 36℃ for 24 hours, and counted using MRS agar medium, and then cultured anaerobically at 36℃ for 48 hours and counted. The results are shown in Table 5.

[0085] Table 5

[0086]

[0087] From the results in Table 5, it can be seen that the vaginal antibacterial care solution prepared in Examples 1-7 of the present invention can achieve a proliferation of Lactobacillus crispatus of more than 3LOG in 24 hours, which can effectively promote the growth of beneficial vaginal microorganisms in the private parts to form a microbial flora protection screen, and effectively reduce or even block HPV infection to maintain the health of the private parts.

[0088] Effect Example 2

[0089] 1. Irritation test

[0090] The vaginal antibacterial care solutions prepared in Examples 1-7 and Comparative Examples 1-18 were used as samples for skin irritation test evaluation. 75 healthy adult rabbits were randomly selected and divided into 25 groups, with 3 rabbits in each group. Four locations on the back of each rabbit were shaved 9 cm 2 The vaginal antibacterial care solutions prepared in Examples 1-7 and Comparative Examples 1-18 were applied to the shaved areas of three rabbits, respectively, once every 8 hours, and the conditions of the applied areas were observed at 24h, 48h and 72h.

[0091] After testing, 75 tested rabbits did not show local irritation reactions such as skin erythema and edema, indicating that the vaginal antibacterial care solution prepared by the present invention is safe, non-irritating, and has no adverse reactions.

[0092] 2. Antipruritic and soothing efficacy test

[0093] Using the samples prepared in Examples 1-7 and Comparative Examples 1-18 as samples, 125 subjects with vulvar itching, pain and odor aged 20-60 were randomly selected for clinical testing, and the 125 subjects were randomly divided into 25 groups, with 5 people in each group. Spray about 2-5 mL of the vaginal antibacterial care solution on the inner and outer vulva, spray once after cleaning the vulva every night, and spray continuously for 20 days. Record the effect scores of the samples in terms of itching and pain relief, heat clearing and dampness drying, and odor removal, and take the average of the scores in the groups; among them, 9-10 points are very good, 7-8 points are good, 5-6 points are average, 3-4 points are poor, and 1-2 points are very poor; the specific results are shown in Table 6.

[0094] Table 6

[0095]

[0096]

[0097] It can be seen from the results in Table 6 that the vaginal antibacterial care solution prepared from the vaginal antibacterial care composition of the present invention has good effects of relieving itching and soothing, clearing heat and dampness, and removing odor, and effectively improves the comfort of the product during use. Figure 1A and B are comparison pictures of the test subject's vulva before and after using the vaginal antibacterial care solution described in Example 5 of the present invention for 20 days, respectively. It can be seen from the pictures that the redness and inflammation of the test subject's vulva have been significantly improved, and the erosive and inflammatory symptoms have been effectively treated.

[0098] Finally, it should be noted that the above embodiments are only used to illustrate the technical solution of the present invention rather than to limit the scope of protection of the present invention. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that the technical solution of the present invention can be modified or replaced by equivalents without departing from the essence and scope of the technical solution of the present invention.

Claims

1. A vaginal antibacterial care composition, characterized in that: The vaginal antibacterial care composition comprises the following components in parts by weight: 1-5 parts of a virus inhibitor, 1-4 parts of a microecological balancer, 2-6 parts of a plant hormone, 1-4 parts of a bactericidal and antipruritic agent, 0.5-2 parts of adenosine triphosphate, and 1-3 parts of an antimicrobial peptide; The virus inhibitor comprises lithospermum officinale extract, phellodendron chinense extract, astragalus extract, propylene glycol, lactic acid bacteria fermentation product and water; The microecological balancing agent comprises alpha-glucan oligosaccharide, bacillus fermentation product, 1,2-hexanediol and water.

2. The vaginal antibacterial care composition according to claim 1, characterized in that: The vaginal antibacterial care composition comprises the following components in parts by weight: 1-1.5 parts of virus inhibitors, 1.5-2.5 parts of microecological balancers, 3.3-5 parts of plant hormones, 1.6-2.4 parts of bactericidal and antipruritic agents, 0.8-1.2 parts of adenosine triphosphate and 1.5-2.5 parts of antibacterial peptides.

3. The vaginal antibacterial care composition according to claim 2, characterized in that: The vaginal antibacterial care composition comprises the following components in parts by weight: 1 part of a virus inhibitor, 2 parts of a microecological balancer, 4 parts of a plant hormone, 2 parts of a bactericidal and antipruritic agent, 1 part of adenosine triphosphate and 2 parts of an antibacterial peptide.

4. The vaginal antibacterial care composition according to claim 1, characterized in that: The virus inhibitor comprises the following components in percentage by mass: 10-25% of lithospermum officinale extract, 10-20% of phellodendron chinense extract, 10-20% of astragalus extract, 10-20% of propylene glycol, 0.5-3% of lactic acid bacteria fermentation product and the balance of water; The microecological balancing agent comprises the following components in percentage by mass: 20-30% of alpha-glucan oligosaccharide, 10-20% of bacillus fermentation product, 2-5% of 1,2-hexanediol and the balance of water.

5. The vaginal antibacterial care composition according to claim 1, characterized in that: The plant hormone is a compound of kudzu root extract, chlorella extract, aloe vera leaf extract and soybean seed extract, and the mass ratio of the total mass of the kudzu root extract, chlorella extract and aloe vera leaf extract to the soybean seed extract is (1-3): (1-3).

6. The vaginal antibacterial care composition according to claim 1, characterized in that: The bactericidal and antipruritic agent comprises oxymatrine and magnolia glycoside; the mass ratio of oxymatrine and magnolia glycoside is oxymatrine: magnolia glycoside=(0.5-2):(0.5-2).

7. A vaginal antibacterial care solution, characterized in that: The invention comprises the vaginal antibacterial care composition according to any one of claims 1 to 6; the mass percentage of the vaginal antibacterial care composition in the vaginal antibacterial care solution is 6.5-24%.

8. The vaginal antibacterial care solution according to claim 7, characterized in that: The vaginal antibacterial care solution also comprises the following components in percentage by weight: 1-3% riboflavin, 0.5-4% poloxamer, 0.02-0.07% bactericide, 0.5-1% solubilizer, 20-30% cosolvent, 0.2-0.8% surfactant, 5-6% pH regulator and the balance of water.

9. The vaginal antibacterial care solution according to claim 8, characterized in that: The bactericide includes benzalkonium chloride; The solubilizing agent comprises at least one of Tween 20, coceth-7, PPG-1-PEG-9 lauryl glycol ether and PEG-40 hydrogenated castor oil; The cosolvent comprises at least one of glycerol and propylene glycol; The surfactant includes disodium cocoamphodiacetate; The pH adjuster includes lactic acid.

10. The method for preparing the vaginal antibacterial care solution according to any one of claims 7 to 9, characterized in that: The following steps are involved: (1) placing the cosolvent and poloxamer in an emulsifier, homogenizing and stirring for 3-7 minutes, the homogenizing speed is 37-40 rpm / min, the stirring speed is 20-30 rpm / min, then adding water, homogenizing 2-4 times, each time for 2-4 minutes, the homogenizing speed is 38-42 rpm / min, the stirring speed is 38-42 rpm / min, then heating to 90° C., adjusting the stirring speed to 22-28 rpm / min, and keeping warm for 35-45 minutes to obtain a mixture I; (2) stirring and mixing the solubilizer and the fungicide to obtain a mixture II, cooling the mixture I to 60-65° C. and adding the mixture II, and then adding a surfactant to obtain a mixture III; (3) cooling the mixture III to 48-52° C., adding adenosine triphosphate, and keeping the temperature for 4-6 minutes, then adding a bactericidal and antipruritic agent, and keeping the temperature for 4-6 minutes to obtain a mixture IV; (4) cooling the mixture IV to 43-47° C., adding a pH regulator, riboflavin, plant hormones, antimicrobial peptides, virus inhibitors and microecological balance agents in sequence, stirring for 3-7 minutes each time a raw material is added, and stirring is continued for 15-30 minutes after the addition is completed to obtain the vaginal antibacterial care solution; The pH value of the vaginal antibacterial care solution is controlled to be 4.2-5.